Study Reveals Barriers and Predictors in Cannabis Use Disorder Treatment

A comprehensive study published in May 2025, titled "An Analysis of 16-Year Trends in Cannabis Use Disorder Treatment: Predictors, Barriers, and Utilization Patterns," sheds light on the evolving landscape of treatment for cannabis use disorder (CUD) in the United States. Conducted by researchers from Florida Atlantic University, the study analyzed data from the National Survey on Drug Use and Health across three time periods: 2003, 2011, and 2019, focusing on individuals diagnosed with CUD. The findings reveal significant barriers to treatment and highlight predictors that influence whether individuals seek help for their condition.

The study indicates a troubling decline in the percentage of individuals receiving treatment for CUD, which decreased from 19% in 2003 to just 13% in 2019. Senior author Brian D. Graves, an assistant professor at Florida Atlantic University, commented on the findings, stating, "Cannabis use disorder treatment is often overshadowed by treatments for other substance use disorders, despite its growing prevalence and impact." Graves emphasized the need to address the barriers that prevent individuals from accessing treatment, which have become increasingly complex over time.

Among the key predictors for receiving treatment, the study identified prior mental health treatment and involvement in community supervision. Notably, the data revealed demographic disparities; in 2003, Hispanic individuals had lower odds of receiving treatment compared to their non-Hispanic white counterparts. However, this trend shifted in subsequent years. Additionally, the study found that prior arrests were associated with a two- to three-fold increase in the likelihood of receiving treatment in later years.

Graves further noted the reasons many individuals do not seek treatment for CUD. Factors such as uncertainty about where to find help, readiness to quit cannabis use, stigma associated with seeking treatment, and affordability issues were cited as significant barriers. He stated, "Our findings highlight an urgent and growing need for targeted outreach and improved education about available treatment options for cannabis use disorder."

The implications of this research extend beyond individual experiences; they reflect broader societal challenges. As cannabis legalization continues to expand across the United States, understanding the dynamics of CUD treatment becomes increasingly important. The study calls for systemic efforts to improve access to care, particularly for marginalized communities disproportionately affected by cannabis use disorder.

In conclusion, the analysis presents a critical look at the shifting landscape of cannabis use disorder treatment over the past 16 years. With declining treatment rates and evolving barriers, there is a pressing need for comprehensive strategies that prioritize accessibility and education, aiming to close the treatment gap and support those in need effectively. This study serves as a vital resource for policymakers, healthcare providers, and advocates seeking to enhance treatment options for cannabis use disorder.